The Global Anti-Venom Market is predicted to grow at a 6.5% CAGR over the forecast period (2017-2023). Anti-venom, which is also known as anti-venom immunoglobulin, venom antiserum, and antivenin, is a medicine made from antibodies that is used for treating specific stings and venomous bites. This antibody product can help to disable the toxins of a venom.
When injected quickly after a sting or a bite, the antibodies present in anti-venom will help in neutralizing the venom, thus potentially saving the limb or life of the victim. Various factors are propelling the anti-venom market growth. These factors, as stated by the MRFR report, include rising incidence of snake bites, rising government funding for research and development activities, unmet medical needs, and increasing patient pool. Additional factors pushing market growth include increasing government assistance, enhancing regulatory framework, and growing awareness about anti-venoms.
On the contrary, the soaring price of anti-venom due to high production cost in various regions, inappropriate clinical application, inconsistent quality standards, lack in availability of anti-venom stock, and inefficient production processes are factors that may restrict the anti-venom market growth over the forecast period.
Avail FREE Sample at https://www.marketresearchfuture.com/sample_request/5859
Leading players profiled in the anti-venom market report include Boston Scientific Corporation, Novo Nordisk A/s, UltiMed, Inc., Terumo Corporation, Stryker Corporation, Smiths Medical, Roboz Surgical Instrument, Owen Mumford, Ltd., Allison Medical, Inc., Medtronic plc, Medline Industries, Inc., Johnson & Johnson Services, Inc, Hu-Friedy Mfg. Co., LLC, cHill-Rom, Allison Medical, Inc., Dickinson and Company, Becton, B. Braun Melsungen AG, Artsana S.p.a., Ypsomed Holding AG, and Thermo Fisher Scientific, among others.
The Market Research Future report provides a wide segmental analysis of the anti-venom market based on end user, product type, mode of action, type of species, and type.
Based on type, the anti-venom market is segmented into small molecule anti-toxins, homologous anti-venom, monovalent heterologous anti-venom, and polyvalent heterologous anti-venom. Of these, the polyvalent heterologous anti-venom segment will have the largest share in the market over the forecast period.
Based on species type, the anti-venom market is segmented into spiders, scorpions, snakes, and others. The snake segment is further segmented into Russell Viper, common krait, common cobra, and others.
Based on the mode of action, the anti-venom market is segmented into myotoxic, cardiotoxic, hemotoxic, neurotoxic, cytotoxic, and others.
Based on product types, the anti-venom market is segmented into spider anti-venom, scorpion anti-venom, snake anti-venom, and others. Of these, the snake anti-venom segment will dominate the market over the forecast period.
Based on end user, the anti-venom market is segmented into surgical centers, ambulatory, clinics, hospitals, and others. Of these, the hospitals segment will lead the market over the forecast period.
LIST OF TABLES
Table 1 Anti-Venom Industry Synopsis, 2017–2023
Table 2 Anti-Venom Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Anti-Venom Market, By Region, 2017–2023, (USD Million)
Table 4 Anti-Venom Market, By Type, 2017–2023, (USD Million)
Table 5 Anti-Venom Market, By Type Of Species, 2017–2023, (USD Million)
Table 6 Anti-Venom Market, By Mode Of Action, 2017–2023, (USD Million)
Table 7 Anti-Venom Market, By Product Type, 2017–2023, (USD Million)
Table 8 Anti-Venom Market, By End-User, 2017–2023, (USD Million)
…To be Continued.
Get a Full Detailed Copy of This Report@ https://www.marketresearchfuture.com/reports/anti-venom-market-5859
July 2019: A research team in Bangladesh for the very first time is reviewing native snake species with an aim to offer local patients with an effective anti-venom at a mass scale production. The researchers will be collecting venoms from various snakes, analyzing their properties, and developing methods for producing the antidote.
Based on the region, the anti-venom market report covers the latest trends and growth opportunities across Europe, the Americas, Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, MRFR asserts
Chapter 11. Global Anti-Venom Market, By Region
11.2.1 North America
11.2.2 South America
11.3.1 Western Europe
22.214.171.124 Rest Of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.5 Republic Of Korea
11.4.6 Rest Of Asia Pacific
11.5 The Middle East & Africa
11.5.1 United Arab Emirates
11.5.2 Saudi Arabia
11.5.6 Rest Of The Middle East & Africa
Avail an Exclusive Discount on https://www.marketresearchfuture.com/check-discount/5859
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Pune – 411028, Maharashtra, India
+1 646 845 9312